Assessing the impact of pain on the life of breast cancer survivors using the Brief Pain Inventory

Abstract

Abstract. [Purpose] This study attempted to assess the impact of pain on the life of breast cancer survivors using the Brief Pain Inventory (BPI). [Subjects and Methods] A cross-sectional study was conducted. Participants comprised 30 women, aged 30-80 years, who had received treatment for breast cancer (surgery and complementary treatment) at least 12 months prior to the study and had reported chronic pain related to the treatment procedures.[Results] The highest scores were found for "mood" (median: 5.00 points; first quartile: 1.00 points; third quartile: 7.25 points), "normal work" (median: 5.00 points; first quartile: 0.00 points; third quartile: 8.00 points), and "sleep" (median: 4.50 points, first quartile: 0.00 points, third quartile: 8.00 points).[Conclusion] Pain exerts a negative impact primarily on mood, normal work, and sleep among breast cancer survivors.

Monitoring changes in quality of life in patients with lung cancer under treatment with chemotherapy and co administration of zoledronic acid by using specialized questionnaires

“…This also reflects as poor sleep quality and dyspnea, established also by other studies with cancer patients. [8,[14][15][16] However there is a contradiction in our findings regarding the effect of pain in quality of life which was positive. This can be attributed to methodological limitations and to the fact that quality of life is a multifaceted notion affected by a variety of parameters.…”

“…[13] Pain in cancer patients affects not only the quality of life [14], but also the ability to work, mobilize and interact with others, resulting in bad psychological condition with frequent sleep disorders leading to a vicious circle. [15,16] Combination of opioids and radiotherapy could prove effective in pain relief in patients with metastatic bone disease [17], but frequent visits to the hospital and tolerance in drugs should be taken in consideration to evaluate QoL. [18] Bone targeted therapies like bisphosphonate and denosumab show high specialty in treating skeletal events and pain due to metastasis.…”

Patient‐reported outcomes in the Translational Breast Cancer Research Consortium

“…As seen in Table , we identified 22 domains to form the basis of our guide. These ranged from health‐related QOL, a very general measure that can be used for patients with multiple cancer sites and stages; to lymphedema, which often is used specifically with patients who have undergone breast surgery; to financial toxicity, a recently identified domain with which to assess the financial and resource‐related difficulties experienced by patients with cancer.…”

Анализ На Разходите За Провеждане На Интравенозна Бифосфонатна Терапия При Пациенти С Онкологични Заболявания

“…Освен това болката, свързана със нарушения на мускулно-скелетната система, може да продължи въпреки използването на опиоиди, така че пациентите да не се възстановят напълно [9]. Болката, свързана с онкологично заболяване, може значително да намали качеството на живот [10], което влияе отрицателно върху настроението, работата, отношенията, способността за движение [11][12] и сън [13][14]. Разстройството на съня може допълнително да наруши прага на толерантност към болката, което може да доведе до порочен кръг от болки [15].…”

“…Редки болести и лекарства сираци 2019;10(1): [12][13][14][15][16][17][18][19] Индиректните разходи всъщност формират част от загубата на социално благосъстояние, дължащо се на болестта, докато останалата част се дължи на загубите от време в здраве вследствие на болка, страдание и скръб, причинени от болестта. Измерването на индиректните разходи не е обект на този анализ.…”